Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats

British Journal of Pharmacology

Volumn 165, Issue 4, 2012, Pages 994-1005

  Polito, Francesca ^a   Marini, Herbert ^a   Bitto, Alessandra ^a   Irrera, Natasha ^a   Vaccaro, Mario ^b   Adamo, Elena Bianca ^a   Micali, Antonio ^b   Squadrito, Francesco ^a   Minutoli, Letteria ^a   Altavilla, Domenica ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

genistein aglycone; oestrogen; raloxifene; skin changes

Indexed keywords

17 ALPHA ETHINYLOESTRADIOL; AGLYCONE; COLLAGEN; ETHINYLESTRADIOL; GELATINASE A; GELATINASE B; GENISTEIN; RALOXIFENE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; MOLECULAR BIOLOGY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SKIN BIOPSY; SKIN FUNCTION; SKIN STRENGTH; TREATMENT DURATION;

ANIMALS; ETHINYL ESTRADIOL; FEMALE; GENISTEIN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, ANIMAL; OVARIECTOMY; PHYTOESTROGENS; POSTMENOPAUSE; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; SKIN AGING; SOYBEANS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856248000     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01619.x     Document Type: Article

References (64)

1. Accorsi-Neto A, Haidar M, Simões R, Simões M, Soares JJ, Baracat E, (2009). Effects of isoflavones on the skin of postmenopausal women: a pilot study. Clinics (Sao Paulo) 64: 505-510.
2. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, et al,. (2003). Estrogen modulates cutaneous wound healing by down regulating macrophage migration inhibitory factor. J Clin Invest 111: 1309-1318. (Pubitemid 36554701)
3. Atmaca A, Kleerekoper M, Bayraktar M, Kucuk O, (2008). Soy isoflavones in the management of postmenopausal osteoporosis. Menopause 15: 748-757.
4. Atteritano M, Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, et al,. (2007). Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 92: 3068-3075. (Pubitemid 47236372)
5. Birkedal-Hansen H, (1995). Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735.
6. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, et al,. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250. (Pubitemid 23103292)
7. Bitto A, Burnett BP, Polito F, Marini H, Levy RM, Armbruster MA, et al,. (2008). Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol 155: 896-905.
8. Bitto A, Burnett BP, Polito F, Levy RM, Marini H, Di Stefano V, et al,. (2009a). Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol 156: 1287-1295.
9. Bitto A, Polito F, Burnett B, Levy R, Di Stefano V, Armbruster MA, et al,. (2009b). Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats. J Endocrinol 201: 321-328.
10. Bolognia JL, Braverman IM, Rousseau ME, Sarrel PM, (1989). Skin changes in menopause. Maturitas 11: 295-304. (Pubitemid 20018230)
11. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardõ FV, Mann GE, et al,. (2006). Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J 20: 2136-2138.
12. Calleja-Agius J, Muscat-Baron Y, Brincat MP, (2007). Skin ageing. Menopause Int 13: 60-64.
13. Campbell L, Emmerson E, Davies F, Gilliver SC, Krust A, Chambon P, et al,. (2010). Estrogen promotes cutaneous wound healing via estrogen receptor β independent of its antiinflammatory activities. J Exp Med 207: 1825-1833.
14. Cassidy A, (2003). Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res 73: 120-126. (Pubitemid 36427779)
15. Chung JH, Eun HC, (2007). Angiogenesis in skin aging and photoaging. J Dermatol 34: 593-600. (Pubitemid 47313250)
16. D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, et al,. (2009). Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause 16: 301-306.
17. Draelos ZD, Blair R, Tabor A, (2007). Oral soy supplementation and dermatology. Cosmet Dermatol 20: 202-204. (Pubitemid 46649549)
18. Emmerson E, Campbell L, Ashcroft GS, Hardmann MJ, (2010). The phytoestrogen genistein promotes wound healing by multiple independent mechanisms. Mol Cell Endocrinol 321: 184-193.
19. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, (1998). The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8: 274-281. (Pubitemid 28427078)
20. Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P, (2009). Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol 219: 449-458.
21. Galeano M, Bitto A, Altavilla D, Minutoli L, Polito F, Calò M, et al,. (2008). Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen 16: 208-217. (Pubitemid 351342130)
22. Gilliver SC, Emmerson E, Campbell L, Chambon P, Hardman MJ, Ashcroft GS, (2010). 17beta-estradiol inhibits wound healing in male mice via estrogen receptor-alpha. Am J Pathol 176: 2707-2721.
23. Goh SH, (1990). The treatment of visible signs of senescence: the Asian experience. Br J Dermatol 122 (Suppl. 35): 105-109. (Pubitemid 20136117)
24. Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin DA, et al,. (2002). Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med 10: 149-153.
25. Harris DM, Besselink E, Henning SM, Go VL, Heber D, (2005). Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 230: 558-568. (Pubitemid 41233155)
26. Hertrampf T, Schleipen B, Offermanns C, Velders M, Laudenbach U, Diel P, (2009). Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol Lett 184: 198-203.
27. Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, et al,. (2006). Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. J Biol Chem 281: 17909-17919. (Pubitemid 44035590)
28. Izumi T, Saito M, Obata A, Arii M, Yamaguchi H, Matsuyama A, (2007). Oral intake of soy isoflavone aglycone improves the aged skin of adult women. J Nutr Sci Vitaminol (Tokyo) 53: 57-62. (Pubitemid 46623919)
29. Jelinsky SA, Choe SE, Crabtree JS, Cotreau MM, Wilson E, Saraf K, et al,. (2008). Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman. BMC Med Genomics 1: 27.
30. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG, (2002). Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 62: 2474-2477. (Pubitemid 34462720)
31. Ju YH, Allred KF, Allred CD, Helferich WG, (2006). Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27: 1292-1299. (Pubitemid 43994865)
32. Kahari VM, Saarialho-Kere U, (1999). Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31: 34-45. (Pubitemid 29134483)
33. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, et al,. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870. (Pubitemid 27089735)
34. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al,. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263. (Pubitemid 28513713)
35. Liu D, Jiang H, Grange RW, (2005). Genistein activates the 3′,5′-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 146: 1312-1320. (Pubitemid 40289318)
36. Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D, et al,. (2005). Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19: 1755-1757. (Pubitemid 41429553)
37. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, et al,. (2007). Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146: 839-847. (Pubitemid 351650484)
38. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, et al,. (2008a). Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 93: 4787-4796.
39. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, et al,. (2008b). OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res 23: 715-720. (Pubitemid 351575025)
40. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, et al,. (2010a). Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutr Metab Cardiovasc Dis 20: 332-340.
41. Marini H, Polito F, Altavilla D, Irrera N, Minutoli L, Calò M, et al,. (2010b). Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats. Br J Pharmacol 160: 1185-1194.
42. Merlo S, Frasca G, Canonico PL, Sortino MA, (2009). Differential involvement of estrogen receptor alpha and estrogen receptor beta in the healing promoting effect of estrogen in human keratinocytes. J Endocrinol 200: 189-197.
43. Moraes AB, Haidar MA, Soares Júnior JM, Simões MJ, Baracat EC, Patriarca MT, (2009). The effects of topical isoflavones on postmenopausal skin: double-blind and randomized clinical trial of efficacy. Eur J Obstet Gynecol Reprod Biol 146: 188-192.
44. Murphy G, Knäuper V, Cowell S, Hembry R, Stanton H, Butler G, et al,. (1999a). Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 878: 25-39. (Pubitemid 29353558)
45. Murphy G, Stanton H, Cowell S, Butler G, Knäuper V, Atkinson S, et al,. (1999b). Mechanisms for pro matrix metalloproteinase activation. APMIS 107: 38-44. (Pubitemid 29133521)
46. North American Menopause Society (2010). Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17: 242-255.
47. Parks WC, (1999). Matrix metalloproteinases in repair. Wound Repair Regen 7: 423-432. (Pubitemid 30027564)
48. Piérard-Franchimont C, Letawe C, Goffin V, Pierard GE, (1995). Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas 22: 151-154.
49. Punnonen R, Vaajalahti P, Teisala K, (1987). Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women. Ann Chir Gynaecol 202: 39-41.
50. Rona C, Vailati F, Berardesca E, (2004). The cosmetic treatment of wrinkles. J Cosmet Dermatol 3: 26-34.
51. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, et al,. (2010). Executive summary: postmenopausal hormone therapy: an endocrine society scientific statement. J Clin Endocrinol Metab 5 (Suppl 1): S1-S66.
52. Sator PG, Schmidt JB, Sator MO, Huber JC, Honigsman H, (2001). The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 39: 43-55. (Pubitemid 32635224)
53. Shah MG, Maibach HI, (2001). Estrogen and skin. An overview. Am J Clin Dermatol 2: 143-150.
54. Shang Y, Brown M, (2002). Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468. (Pubitemid 34270263)
55. Skovgaard GR, Jensen AS, Sigler ML, (2006). Effect of a novel dietary supplement on skin aging in post-menopausal women. Eur J Clin Nutr 60: 1201-1206. (Pubitemid 44489969)
56. Son ED, Lee JY, Lee S, Kim MS, Lee BG, Chang IS, et al,. (2005). Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo. J Invest Dermatol 124: 1149-1161. (Pubitemid 40847401)
57. Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, et al,. (2003). Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 114: 470-476. (Pubitemid 36515109)
58. Taylor CK, Levy RM, Elliott JC, Burnett BP, (2009). The Effect of Genistein Aglycone on Cancer and Cancer Risk: a review of in vitro, preclinical and clinical studies. Nutrition Reviews 67: 398-415.
59. Thornton MJ, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O'Driscoll J, et al,. (2003). Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 12: 181-190. (Pubitemid 36939119)
60. Tsukahara K, Nakagawa H, Moriwaki S, Kakuo S, Ohuchi A, Takema Y, et al,. (2004). Ovariectomy is sufficient to accelerate spontaneous skin ageing and to stimulate ultraviolet irradiation-induced photoageing of murine skin. Br J Dermatol 151: 984-994. (Pubitemid 39573886)
61. Verdier-Sévrain S, (2007). Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. Climacteric 10: 289-297. (Pubitemid 47123951)
62. Verdier-Sévrain S, Bonté F, Gilchrest B, (2006). Biology of estrogens in skin: implications for skin aging. Exp Dermatol 15: 83-94.
63. Werb Z, Chin JR, (1998). Extracellular matrix remodeling during morphogenesis. Ann N Y Acad Sci 857: 110-118. (Pubitemid 28526260)
64. Wolff EF, Narayan D, Taylor HS, (2005). Long-term effects of hormone therapy on skin rigidity and wrinkles. Fertil Steril 84: 285-288. (Pubitemid 41125242)